The aim of this study was to monitor the concentration of antibodies against Newcastle disease after vaccination of laying hens at the beginning and in the end of the laying period. The study was carried out in one commercial flock of laying hens in Opatovice in the Czech Republic in the years 2008-2010. A total of 280 samples of blood sera were taken from laying hens coming from four poultry houses. The sera were tested by the haemagglutination inhibition test according to the OIE Manual. Virological testing was conducted as a consequence of atypical results of serological testing. Newcastle disease virus RNA was proved by the RT-nested PCR method in the pooled tissue samples of 5 hens, in the samples of intestines with ileocaecal tonsila, in trachea and also in one swab sample from the environment of one house. Based on sequencing analysis and subsequent phylogenetic analysis, the virus was identified as a low pathogenic strain of paramyxovirus (PMV-1). This low pathogenic strain did not have any impact on the health of laying hens.
Newcastle disease (ND) is an infectious, highly contagious viral disease of the gallinaceous fowl affecting all age categories, caused by the Newcastle disease virus (NDV) belonging to the family Paramyxoviridae (PMV-1), genus Avulavirus. Viral genome is non-segmented, formed by a single stranded RNA with negative polarity (-ss RNA), coding for six proteins: NP -nucleoprotein, M -matrix protein, F -fusion protein, HN -haemagglutinin-neuraminidase protein, P -phosphorylated nucleocapsideassociated protein and L-RNA-dependent RNA polymerase (Kattenbelt et al. 2006) . The virulence of the NDV is closely related to the variable cleavability of the F protein due to distinct amino acid composition of the "cleavage site" (L e e et al. 2004; de Leeuw et al. 2005) . Studies comparing amino acid sequences of the F protein proved that strains which are virulent for poultry have the 112 R/K-R-Q-K/R-R-F 117 amino acid sequence at the "cleavage site", whereas low virulence strains have the 112 G/E-K/R-Q-G/E-R-L 117 sequence in this area (Collins et al. 1993; L i u et al. 2003) . Antigenic diversity of paramyxoviruses was confirmed in Australia between 1998-2000 (Annex to the EFSA Journal 2007).
Newcastle disease has a big socio-economic impact (Awan et al. 1994; Alexander 2000; S e a l et al. 2000) . Significant variability of clinical symptoms, which depends on the virulence of ND virus strains, is typical for this disease. Lentogenic virus strains cause only mild or no clinical symptoms, in particular in the adult birds, while the mesogenic strains cause higher mortality. Velogenic strains cause severe gastrointestinal, respiratory and/or nervous symptoms and mortality rate reaches almost 100% (Banerjee et al. 1994) .
Despite the antibody titres, infected hens excrete the virus via faeces; the virus is then transmitted transovarially into the eggs and infected chickens subsequently hatch from such eggs (Capua et al. 1993) . The transmission of the NDV lentogenic strains were shown by Pospíšil et al. 1991 who detected the virus directly in the embryos of hatching eggs and in the intestinal contents of the non-vaccinated chickens up to 25 days after hatching, despite the fact that the parental flock was vaccinated and the specific maternal antibodies were present in the chickens. Newcastle disease virus disappeared from the chickens with no induction of the active production of antibodies; these chickens reacted to the vaccination by only very low and variable titres of antibodies.
The prevention mainly relies on flock protection from the appearance and spread of the infection into the flocks and on the specific ND immunoprophylaxis. The chickens are vaccinated using live vaccines usually 2-3 ×, and around the age of 18 weeks they are revaccinated with inactivated vaccine with the aim to ensure the protection of laying hens until the end of the laying period. Cases of a lack of post-vaccination immunity against ND were reported in 2007 and 2008 despite these measures being in place. This led us to monitor the post-vaccination antibodies and to the virological testing of laying hens to identify the causes for the unusual development of post-vaccination immunity.
Materials and Methods

Sample collection
The monitoring of antibodies against ND was carried out in a commercial flock of laying hens in Opatovice in the Czech Republic. There were 9 poultry houses, from which 4 poultry houses (No. In the years 2008-2010, a total of 280 blood samples were taken from the commercial laying hens and tested for the ND post-vaccination immunity. In 2008, the group of hens in house No. 4 was monitored during the laying period; 20 blood samples were taken at 23, 35, 53 and 71 weeks of age, a total 80 samples. In the same year, groups of hens from houses No. 2, 8 and 10 were monitored too; 20 blood samples were taken from each house at the beginning of the laying period (around the age of 20 weeks) and at the end of the laying period (around the age of 50 weeks). In 2009, the groups of hens from two poultry houses (No. 4 and 8) were monitored again; 20 blood samples were taken from each house at the beginning of the laying period and before the end of the laying period.
Haemagglutination inhibition test
The haemagglutination inhibition (HI) test was used for the detection of the presence of the antibodies against NDV according to the OIE Manual (2010). This laboratory work was done at the State Veterinary Institute Olomouc. Newcastle disease virus strain LaSota (originally from the vaccine Avipest) and NDV antiserum (VLA Weybridge, UK) was used for HI test.
Virological testing
The tissue samples from 5 randomly selected hens from house No. 4 were used for the virological testing. Brain, trachea, lungs, liver, kidney and caecum with ileocaecal tonsila were taken as the suspected organs. Five swab samples (one sample from the ceiling fan, one sample from the rear fan, one sample from the side fan and two samples from the feeders) from poultry house No. 4 were also taken in order to ensure a complete virological investigation.
RNA extraction and Reverse transcriptase -nested polymerase chain reaction (RT-nested PCR)
Total RNA was isolated using RNeasy Mini Kit (Quiagen, Germany) according to the manufacturer's instructions. The F protein gene sequence (n. AY338284) acquired from the GenBank (NCBI) was used for RT-nested PCR development. Two sets of primers based on a conserved region of the F protein gene of NDV were designed. The sequence of a sense primer was 5´GAA AAA ACA CGG GTA GAA GA 3´, the sequence of an antisense primer was 5´GAG CTG AGT TGG TTG TTC C 3´ for the RT-PCR and 5´GTC AAC ATA TAC ACC TCA TCC CAG A 3´ and 5´GCA TTC TGG TTG GCT TGT ATC A 3´ for the nested PCR. The part of amplification product from nested PCR (298 bp) is a sequence of the "cleavage site". SYBR 1-STEP QRT-PCR kit for a one-step RT-PCR (Invitrogen, USA) was used with a 20-ml mixture under the following conditions: 0.4 ml of RT/Taq Mix, 400 mM (each) dNTP and 1.6 mM MgCl 2 . Reverse transcription was performed with 3 ml of total RNA at 42 °C for 50 min. The PCR amplification programme consisted of 40 cycles of 94 °C for 35 s, followed by 47 °C for 35 s and 72 °C for 90 s. Finally, extension was at 72 °C for 5 min. PPP Master Mix (Top Bio, Czech Republic) was used for nested PCR. PCR reaction was performed with 1 ml of amplification product from RT-PCR. The PCR amplification programme consisted of 40 cycles of 94 °C for 35 s, followed by 54 °C for 35 s and 72 °C for 60 s. Finally, extension was at 72 °C for 5 min. The amplified products after nested PCR were analysed by electrophoresis on a 2% agarose gel stained with ethidium bromide. The fragment size (298 bp) was compared with the DNA ladder (O'Gene Ruler TM DNA Ladder Mix, Fermentas, USA).
Sequencing of PCR product and phylogenetic analysis The PCR product (298bp) was purified by QIAquick Gel Extraction Kit (Qiagen, Germany). The sequencing of PCR product nucleotides was performed in both directions with the help of capillary electrophoresis using a laserinduced phosphorescence detector and an automated genetic analyser "CEQ™ 8000 Genetic Analyzer" (Beckman Coulter, USA) at the Department of Biology and Wildlife Diseases, University of Veterinary and Pharmaceutical Science Brno, Czech Republic. Phylogenetic analysis was performed from the obtained nucleotide sequence of the F protein gene including the F 0 "cleavage site" and deduced amino acid sequence compared with sequences in GenBank using AlignX program (Vector NTI, 5.5, INFORMAX, inc.)
Results
Houses No. 2 and 10
The Table 1 . Newcastle disease virus was detected using RT-nested PCR in 3 pooled samples and in 4 samples of caeca with ileocaecal tonsilla and in two samples of trachea taken from the hens from house No. 4. The virus was not detected in any samples of the brain, lungs and liver. The virus was also detected in one swab sample of dust from the environment. The size of the PCR product was 298 bp.
The virus was identified as of low virulence, the "cleavage site" area contained the amino acid motive
. The strain was named as NDV/Opatovice-cz/2010 (Fig. 1) .
Discussion
The Institute for State Control of Veterinary Biologicals and Medicines started to provide random monitoring of post-vaccination antibodies against ND in some poultry flocks in order to verify the efficacy of the vaccination. The dynamics of the postvaccinational antibodies in hens from houses No. 2 and 10 showed a pattern similar to the one identified during the pre-authorisation field testing of certain inactivated vaccines, i.e. there was a decline in the antibody titres after the peak is reached at the age of approximately 30-35 weeks and, as a result, the antibody titre was lower at the end of the laying period but still provided protection. However, we could find also an atypical course of the post-vaccinational immunity in hens from poultry houses No. 4 and 8, characterized by either only small decline or even an increase in the titre of the post-vaccinational antibodies with results reaching the value of up to 2 048 when tested by the HIT. Laying hens housed in those houses were clinically healthy throughout the laying period. Similar observations were made by other authors in some other countries, e.g. in Italy (Capua et al. 1993) .
The presence of a field paramyxovirus in hens was suspected when an unusual pattern of the postvaccinational immunity against ND was recorded. Randomly selected hens were sacrificed and dissected at the end of the laying period. Samples were taken from those animals for the RT-nested PCR testing to demonstrate the avian paramyxovirus. The brain, trachea, lungs, liver and caecum with ileocaecal tonsilla were taken as the suspected organs. Tests to detect the virus were at first carried out in mixed samples and, thereafter, in relevant organs as well as in samples of dust collected from different sites in the poultry house to detect the virus in the environment. PMV-1 was identified in the mixed organ samples of 5 hens, in the trachea and in the caecum with the ileocaecal tonsilla. PMV-1 was identified as a low virulent strain (named as NDV/Opatovice-cz/2010) with the amino acid motive (Collins et al. 1993; Kant et al. 1997; Gohm et al. 2000; Liu et al. 2003) by nucleotide sequencing of the "cleavage site" area in the sequence of the F protein gene. The strain is found in the phylogenetic tree at the branch common to the strains isolated in the 1990s by Pospíšil et al. (1991) from young chickens in the Czech Republic. The NDV/Opatovice-cz/2010 strain is also close to the LaSota and Clone 30 vaccination strains in the phylogenetic tree. This low virulence paramyxovirus was isolated from the environment of poultry house No. 4, and it spread in the flock by the aerogenous route. Neither health status nor productivity of the hens were affected by the strain, but it continuously stimulated the production of antibodies. In the case of our commercial laying hen farm, the presence of the low virulence paramyxovirus in the flock had a positive impact on the level and persistence of post-vaccination immunity throughout the laying period and helped to create a steady flock protection against ND with no impairment of the laying hens' productivity. When such situation occurs in the parent flock, the field strain can be transmitted to the offspring transovarially, resulting in the immunotolerance status followed by lower immune response to the vaccination in the affected offspring. The natural transovarial transmission of the NDV was repeatedly proved in the case of the parent flocks by virus isolation from the chicken embryos and from dayold chickens (Pospíšil et al. 1991; Capua et al. 1993) , resulting in the impairment of the induction and level of the post-vaccinational immunity of the affected flock (Pospíšil et al. 1991) . There is also a real risk with respect to the proved antigenic diversity (Annex to the EFSA Journal 2007) of a parallel infection by different ND virus strains in a host (vaccination and field strain) which may result in the origin of new NDV strains with variable pathogenicity.
This study demonstrated the presence of a low pathogenic strain of paramyxovirus (PMV-1) in the tissues of laying hens and also in the dust of poultry house. The presence of this virus stimulated immunity of hens against ND but had no negative impact on health and productivity of laying hens.
